165 results
Page 2 of 9
6-K
ocviezw2y
21 Dec 22
Current report (foreign)
6:01am
6-K
8d68g327p8 jznm
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
EX-99.1
5or6a
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
gccbcs1fn bs
8 Dec 22
Current report (foreign)
6:46am
6-K
g549x00cvd0kk0m7gr
4 Nov 22
Current report (foreign)
6:01am
6-K
mr8oh
14 Oct 22
Current report (foreign)
7:36am
6-K
6g0cr
4 Oct 22
Current report (foreign)
6:06am
6-K
EX-99.1
3hfhf1q
23 Aug 22
Current report (foreign)
6:13am
6-K
90rysczppmjd9bgp8
4 Aug 22
Current report (foreign)
6:07am
6-K
be7sly
11 Jul 22
Current report (foreign)
6:05am
6-K
6pe506j5
29 Jun 22
Current report (foreign)
6:02am
6-K
4vfckj h4s
24 Jun 22
Current report (foreign)
6:08am
6-K
pcsqj7slep
10 Jun 22
Current report (foreign)
6:00am
6-K
esf4vy8wxeg1kci
1 Jun 22
Current report (foreign)
6:08am
6-K
s1state y0ea
31 May 22
Current report (foreign)
6:20am
6-K
ze6cmc
31 May 22
Current report (foreign)
6:18am
6-K
EX-99.1
ftsympso2oliy
31 May 22
Current report (foreign)
6:14am
6-K
EX-99.1
fsw ibdvk54
31 May 22
Current report (foreign)
6:07am
6-K
xubfhj t67
11 May 22
Current report (foreign)
6:11am